Insider trade

Officer sold ~$71K of BRKR shares in the open market

Traded Mar 13, 2026 · Filed Mar 16, 2026

Why it stands out

Bruker's EXEC VP&PRES BRUKER NANO INC. sold $71K of Bruker shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$25K–$100KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$70,880

Shares × reported transaction price

Timing vs results

29 days after results of Feb 12, 2026, 54 days before results of May 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+6.1%	−2.6%	+8.8%
30 days	+15.4%	+4.6%	+10.8%
90 days	+67.8%	+12.5%	+55.3%
180 days	+56.1%	+13.4%	+42.6%

Past results only. Not a forecast.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

7mo ago

Derivative exercise or conversion — not an open-market buy.

7mo ago

Derivative exercise or conversion — not an open-market buy.

8mo ago

Compensation award — excluded from discretionary-purchase analysis.